Literature DB >> 11319969

Sexually transmitted diseases: magnitude, determinants and consequences.

S O Aral1.   

Abstract

Sexually transmitted diseases (STDs) including human immuno-deficiency virus (HIV) infections constitute a major reproductive health burden for sexually-active individuals. The short-term and long-term consequences of STD have been well documented and include genital and other cancers, pelvic inflammatory disease, ectopic pregnancy, infertility, and adverse outcomes of pregnancy including pre-term delivery and low birth weight. The burden of sexually transmitted infections falls disproportionately on the young, the poor, minorities and women. At the societal level, there is a continuing need to educate people, particularly adolescents, about their risk for STDs and their sequelae and to increase the use of barrier methods including condoms. Policy decisions that facilitate more open discussion of sexuality and STDs, and that expand the accessibility and acceptability of sexual risk assessment, STD screening and treatment services would help decrease STD rates in the United States to levels similar to those observed in other industrialized countries.

Entities:  

Mesh:

Year:  2001        PMID: 11319969     DOI: 10.1258/0956462011922814

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  15 in total

1.  Risky parental behavior and adolescent sexual activity at first coitus.

Authors:  Esther I Wilder; Toni Terling Watt
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

2.  An Ecological Model of Stressors Experienced by Youth Newly Diagnosed With HIV.

Authors:  Sybil G Hosek; Gary W Harper; Diana Lemos; Jaime Martinez
Journal:  J HIV AIDS Prev Child Youth       Date:  2008

3.  Review of Clinical Trials Testing the Effectiveness of Clinician Intervention Approaches to Prevent Sexually Transmitted Diseases in Adolescent Outpatients.

Authors:  Bradley O Boekeloo; Melinda A Griffin
Journal:  Curr Pediatr Rev       Date:  2005-06

4.  Risk Reduction Therapy for Adolescents: Targeting Substance Use and HIV/STI-Risk Behaviors.

Authors:  Michael R McCart; Ashli J Sheidow; Elizabeth J Letourneau
Journal:  Cogn Behav Pract       Date:  2014-05-01

Review 5.  Burden of human papillomavirus infection and related comorbidities in men: implications for research, disease prevention and health promotion among Hispanic men.

Authors:  Vivian Colón-López; Ana P Ortiz; Joel Palefsky
Journal:  P R Health Sci J       Date:  2010-09       Impact factor: 0.705

6.  Assessing maternal risk for fetal-infant mortality: a population-based study to prioritize risk reduction in a healthy start community.

Authors:  Catherine L Kothari; Annie Wendt; Oemeeka Liggins; Jacqueline Overton; Luz del Carmen Sweezy
Journal:  Matern Child Health J       Date:  2011-01

7.  Predictors of male partner treatment for sexually transmitted infection.

Authors:  Gina M Secura; Fidel A Desir; Jennifer L Mullersman; Tessa Madden; Jenifer E Allsworth; Jeffrey F Peipert
Journal:  Sex Transm Dis       Date:  2012-10       Impact factor: 2.830

8.  The benefit of health insurance coverage of contraceptives in a population-based sample.

Authors:  Ann Kurth; Marcia Weaver; David Lockhart; Lori Bielinski
Journal:  Am J Public Health       Date:  2004-08       Impact factor: 9.308

9.  A randomized controlled trial for reducing risks for sexually transmitted infections through enhanced patient-based partner notification.

Authors:  Tracey E Wilson; Matthew Hogben; Edmond S Malka; Nicole Liddon; William M McCormack; Steve R Rubin; Michael A Augenbraun
Journal:  Am J Public Health       Date:  2008-06-12       Impact factor: 9.308

10.  Lack of utility of risk score and gynecological examination for screening for sexually transmitted infections in sexually active adolescents.

Authors:  Eleuse M B Guimarães; Mark D C Guimarães; Maria Aparecida S Vieira; Nádia M Bontempo; Mirian S S Seixas; Mônica S D Garcia; Lyana E S Daud; Rejane L M Côrtes; Maria de Fátima C Alves
Journal:  BMC Med       Date:  2009-03-11       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.